SCHEMBL9635564

SCHEMBL9635564

N#Cc1cc(=O)c2ccc(OCc3ccc(OC(=O)c4ccccc4)c(OCc4ccc5ccccc5n4)c3)cc2o1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYSLTR1 Q9Y271 10/20 0.47
GPBAR1 Q8TDU6 1/20 0.47
PPARG P37231 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9635505 0.91 CYSLTR1 (0.48) CYSLTR1GPBAR1
SCHEMBL9757410 0.85 CYSLTR1 (0.50) CYSLTR1GPBAR1PPARG
SCHEMBL9636904 0.85 CYSLTR1 (0.53) CYSLTR1GPBAR1
SCHEMBL9635545 0.83 CYSLTR1 (0.50) CYSLTR1GPBAR1
SCHEMBL9637044 0.79 CYSLTR1 (0.46) CYSLTR1GPBAR1
SCHEMBL10463718 0.77 CYSLTR1 (0.60) CYSLTR1GPBAR1
SCHEMBL9636900 0.76 CYSLTR1 (0.51) CYSLTR1GPBAR1
SCHEMBL9757042 0.76 CYSLTR1 (0.52) CYSLTR1GPBAR1
SCHEMBL9636896 0.75 ALOX5 (0.48) CYSLTR1GPBAR1
SCHEMBL9635547 0.75 CYSLTR1 (0.65) CYSLTR1GPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5082849-A Antiinflammatory agents or antiallergens AVENTIS PHARMACEUTICALS INC. 1992-01-21 US disclosed
EP-0434827-A4 QUINOLINYL-BENZOPYRAN DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4? 1992-01-08 EP disclosed
EP-0434827-A1 QUINOLINYL-BENZOPYRAN DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4? RORER INTERNATIONAL (HOLDINGS), INC. (US) 1991-07-03 EP disclosed
WO-1991001123-A2 QUINOLINYL-BENZOPYRAN DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D¿4? RORER INTERNATIONAL (OVERSEAS) INC. (US) 1991-02-07 WO disclosed
US-4977162-A Quinolinyl-chromone derivatives and use for treatment of hypersensitive ailments RORER PHARMACEUTICAL CORPORATION (US) 1990-12-11 US disclosed